Method for formulating large diameter synthetic membrane vesicles

US9737482B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9737482-B2
Application numberUS-201313786933-A
CountryUS
Kind codeB2
Filing dateMar 6, 2013
Priority dateApr 9, 2010
Publication dateAug 22, 2017
Grant dateAug 22, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention generally relates to the field of pharmaceutical sciences. More specifically, the present invention includes apparatus and devices for the preparation of pharmaceutical formulations containing large diameter synthetic membrane vesicles, such as multivesicular liposomes, methods for preparing such formulations, and the use of specific formulations for therapeutic treatment of subjects in need thereof. Formation and use of the pharmaceutical formulations containing large diameter synthetic membrane vesicles produced by using the apparatus and devices for therapeutic treatment of subjects in need thereof is also contemplated.

First claim

Opening claim text (preview).

What is claimed is: 1. An evaporation apparatus, comprising: a solvent removal vessel having a top, a bottom and a circular wall; at least one atomizing nozzle; a carrier gas entrance orifice; a solvent removal gas exit orifice centrally connected to the top; and a product exit orifice connected to the bottom of the vessel, wherein the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel, wherein the tube is fitted with a narrowing cone. 2. The apparatus of claim 1 , wherein the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel, wherein the tube is fitted with a narrowing cone and an annular ring. 3. The apparatus of claim 1 , wherein the ratio of the inside diameter of the solvent removal vessel to the diameter of the narrowing cone of the solvent removal gas exit orifice is between approximately 5:1 and 100:1. 4. The apparatus of claim 1 , wherein the ratio of the inside diameter of the solvent removal vessel to the diameter of the narrowing cone of the solvent removal gas exit orifice is between approximately 20:1 and 60:1. 5. A process for preparing a suspension of multivesicular liposomes using the evaporation apparatus of claim 1 , comprising: introducing large diameter synthetic membrane vesicles pre-droplets to the solvent removal vessel, wherein the large diameter synthetic membrane vesicles pre-droplets comprise a first component core and an aqueous phase shell; applying a carrier gas in a tangential direction to the circular wall through the carrier gas entrance orifice; and removing a solvent removal gas through the solvent removal gas exit orifice to provide the suspension of multivesicular liposomes. 6. The process of claim 5 , wherein the multivesicular liposomes further comprises bupivacaine. 7. The apparatus of claim 1 , wherein the apparatus further comprises at least two carrier gas entrance orifices. 8. The apparatus of claim 1 , wherein at least part of the solvent removal vessel is jacketed. 9. The apparatus of claim 1 , wherein the atomizing nozzle is mounted to and extending through the top of the solvent removal vessel. 10. The apparatus of claim 1 , wherein the top of the solvent removal vessel comprises a lid. 11. The apparatus of claim 1 , further comprising a rinse nozzle mounted to and extending through the top of the solvent removal vessel. 12. The apparatus of claim 1 , wherein the circular wall has a central axis and the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel residing along the central axis. 13. The apparatus of claim 12 , wherein the atomizing nozzle is angled at least 5 degrees measured off the central axis of the wall and in a plane parallel to the wall nearest to it. 14. The apparatus of claim 1 , wherein the tube extends from about ⅓ to about ⅘ of the way into the solvent removal vessel. 15. The apparatus of claim 1 , wherein the tube extends about ⅔ of the way into the solvent removal vessel. 16. The apparatus of claim 1 , wherein a bottom tip of the narrowing cone diameter is from about 1/1000 to about ⅕ of the diameter of the inside of the solvent removal vessel. 17. The apparatus of claim 1 , wherein the solvent removal gas exit orifice diameter is less than 1/10 of a diameter of the inside of the solvent removal vessel. 18. The apparatus of claim 1 , wherein the at least one atomizing nozzle comprises: a first fluid conduit and a second fluid conduit each having at least one entrance orifice and at least one exit orifice; a fluid contacting chamber having a top comprising at least one entrance orifice and having a bottom comprising at least one exit orifice and connecting to the at least one exit orifice of the first fluid conduit; and a third fluid conduit, wherein the third fluid conduit annularly surrounds a portion of the fluid contacting chamber. 19. The apparatus of claim 1 , wherein the at least one atomizing nozzle comprises: a first fluid conduit, a second fluid conduit and a third fluid conduit each having at least one entrance orifice and at least one exit orifice; a first fluid contacting chamber having a top comprising at least one entrance orifice and having a bottom comprising at least one exit orifice and connecting to the at least one exit orifice of the first fluid conduit, wherein the second fluid conduit annularly surrounds a portion of the first fluid contacting chamber; a second fluid contacting chamber having a top comprising at least one entrance orifice and having a bottom comprising at least one exit orifice and connecting to the at least one exit orifice of the first fluid contacting chamber, wherein the third fluid conduit annularly surrounds a portion of the second fluid contacting chamber; and a fourth fluid conduit, wherein the fourth fluid conduit annularly surrounds a portion of the second fluid contacting chamber. 20. The apparatus of claim 18 , wherein the tube is fitted with an annular ring. 21. The apparatus of claim 18 , wherein the ratio of the inside diameter of the solvent removal vessel to the diameter of the narrowing cone of the solvent removal gas exit orifice is between approximately 5:1 and 100:1. 22. The apparatus of claim 18 , wherein the ratio of the inside diameter of the solvent removal vessel to the diameter of the narrowing cone of the solvent removal gas exit orifice is between approximately 20:1 and 60:1. 23. The apparatus of claim 18 , wherein at least part of the solvent removal vessel is jacketed. 24. The apparatus of claim 18 , wherein the atomizing nozzle is mounted to and extending through the top of the solvent removal vessel. 25. The apparatus of claim 18 , wherein the top of the solvent removal vessel comprises a lid. 26. The apparatus of claim 18 , further comprising a rinse nozzle mounted to and extending through the top of the solvent removal vessel. 27. The apparatus of claim 18 , wherein the circular wall has a central axis and the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel residing along the central axis. 28. The apparatus of claim 27 , wherein the atomizing nozzle is angled at least 5 degrees measured off the central axis of the wall and in a plane parallel to the wall nearest it. 29. The apparatus of claim 18 , wherein the tube extends from about ⅓ to about ⅘ of the way into the solvent removal vessel. 30. The apparatus of claim 18 , wherein the tube extends about ⅔ of the way into the solvent removal vessel. 31. The apparatus of claim 18 , wherein a bottom tip of the narrowing cone diameter is from about 1/1000 to about ⅕ of the diameter of the inside of the solvent removal vessel. 32. The apparatus of claim 18 , wherein the solvent removal gas exit orifice diameter is less than 1/10 of a diameter of the inside of the solvent removal vessel. 33. The apparatus of claim 19 , wherein the tube is fitted with an annular ring. 34. The apparatus of claim 19 , wherein the ratio of the inside diameter of the solvent removal vessel to the diameter of the narrowing cone of the solvent removal gas exit orifice is between approximately 5:1 and 100:1. 35. The apparatus of claim 19 , whe

Assignees

Inventors

Classifications

  • Anaesthetics · CPC title

  • Local anaesthetics · CPC title

  • Drying and spraying · CPC title

  • Non condensed piperidines, e.g. piperocaine · CPC title

  • by evaporation of the solvent (apparatus therefor B01J13/043) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9737482B2 cover?
The present invention generally relates to the field of pharmaceutical sciences. More specifically, the present invention includes apparatus and devices for the preparation of pharmaceutical formulations containing large diameter synthetic membrane vesicles, such as multivesicular liposomes, methods for preparing such formulations, and the use of specific formulations for therapeutic treatment …
Who is the assignee on this patent?
Pacira Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification A61K9/1271. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).